This case report highlights the potential for aspirin resistance in diabetic patients, possibly driven by glycemic excursions and post-prandial hyperglycemia.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for aspirin resistance in diabetes via glycemic excursions; does not support practice change and requires prospective trials.
Diabetes is characterised by development of specific microvascular complications and by a high incidence of accelerated atherosclerosis. Several Authors demonstrated that post-prandial hyperglycaemia is certainly an independent risk factor of vascular complications in type 2 diabetes. The endothelial dysfunction, the oxidative stress, the post-prandial hyperglycaemia and the haemostatic and thrombotic parameters alterations are the principal causes for the cardiovascular risk increase in diabetic patient. For this reason many studies on anti-platelet therapy have been made in order to reduce thrombotic complication of diabetes mellitus. However, data suggest that the clinical efficacy of low-dose aspirin in patients with diabetes is substantially lower than in individuals without diabetes. Indeed, several evidences support the hypothesis that diabetes might represent a case of “aspirin resistance”.
No takes yet. Share an insight, caveat, or question.
Fava et al. (2010) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: